EKF DIAGNOST.HLDGS.LS-01
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more
Market Cap & Net Worth: EKF DIAGNOST.HLDGS.LS-01 (LYF)
EKF DIAGNOST.HLDGS.LS-01 (F:LYF) has a market capitalization of $121.49 Million (€118.36 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #18128 globally and #1897 in its home market, demonstrating a -3.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EKF DIAGNOST.HLDGS.LS-01's stock price €0.27 by its total outstanding shares 431963112 (431.96 Million).
EKF DIAGNOST.HLDGS.LS-01 Market Cap History: 2020 to 2026
EKF DIAGNOST.HLDGS.LS-01's market capitalization history from 2020 to 2026. Data shows change from $290.03 Million to $121.49 Million (-9.99% CAGR).
EKF DIAGNOST.HLDGS.LS-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EKF DIAGNOST.HLDGS.LS-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LYF by Market Capitalization
Companies near EKF DIAGNOST.HLDGS.LS-01 in the global market cap rankings as of March 18, 2026.
Key companies related to EKF DIAGNOST.HLDGS.LS-01 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
EKF DIAGNOST.HLDGS.LS-01 Historical Marketcap From 2020 to 2026
Between 2020 and today, EKF DIAGNOST.HLDGS.LS-01's market cap moved from $290.03 Million to $ 121.49 Million, with a yearly change of -9.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €121.49 Million | -0.72% |
| 2025 | €122.38 Million | -13.21% |
| 2024 | €141.00 Million | -10.17% |
| 2023 | €156.96 Million | -30.60% |
| 2022 | €226.18 Million | -37.92% |
| 2021 | €364.34 Million | +25.62% |
| 2020 | €290.03 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of EKF DIAGNOST.HLDGS.LS-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $121.49 Million USD |
| MoneyControl | $121.49 Million USD |
| MarketWatch | $121.49 Million USD |
| marketcap.company | $121.49 Million USD |
| Reuters | $121.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.